Suppr超能文献

发现并表征多梳抑制复合物 1 染色质域的细胞有效正变构调节剂 CBX7。

Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7.

机构信息

Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Dr. Bohr-Gasse 3, 1030 Vienna, Austria; Department of Biochemistry and Molecular Medicine and Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.

出版信息

Cell Chem Biol. 2019 Oct 17;26(10):1365-1379.e22. doi: 10.1016/j.chembiol.2019.07.013. Epub 2019 Aug 15.

Abstract

Polycomb-directed repression of gene expression is frequently misregulated in human diseases. A quantitative and target-specific cellular assay was utilized to discover the first potent positive allosteric modulator (PAM) peptidomimetic, UNC4976, of nucleic acid binding by CBX7, a chromodomain methyl-lysine reader of Polycomb repressive complex 1. The PAM activity of UNC4976 resulted in enhanced efficacy across three orthogonal cellular assays by simultaneously antagonizing H3K27me3-specific recruitment of CBX7 to target genes while increasing non-specific binding to DNA and RNA. PAM activity thereby reequilibrates PRC1 away from H3K27me3 target regions. Together, our discovery and characterization of UNC4976 not only revealed the most cellularly potent PRC1-specific chemical probe to date, but also uncovers a potential mechanism of Polycomb regulation with implications for non-histone lysine methylated interaction partners.

摘要

多梳抑制基因表达在人类疾病中经常失调。本研究采用一种定量且靶向特异性的细胞测定方法,发现了第一个强效的核酸结合的 CBX7 正别构调节剂(PAM)肽模拟物 UNC4976,CBX7 是多梳抑制复合物 1 的一个染色质域甲基赖氨酸读取器。UNC4976 的 PAM 活性通过同时拮抗 H3K27me3 特异性募集 CBX7 到靶基因,同时增加与 DNA 和 RNA 的非特异性结合,从而增强了三种正交细胞测定中的功效。PAM 活性因此使 PRC1 从 H3K27me3 靶区域重新平衡。总之,我们对 UNC4976 的发现和表征不仅揭示了迄今为止最具细胞活性的 PRC1 特异性化学探针,而且还揭示了多梳调控的潜在机制,这对非组蛋白赖氨酸甲基化相互作用伙伴具有重要意义。

相似文献

2
Reprogramming CBX8-PRC1 function with a positive allosteric modulator.用正变构调节剂重编程 CBX8-PRC1 功能。
Cell Chem Biol. 2022 Apr 21;29(4):555-571.e11. doi: 10.1016/j.chembiol.2021.10.003. Epub 2021 Oct 28.
3
Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2.发现EED的拟肽配体作为PRC2的变构抑制剂
ACS Comb Sci. 2017 Mar 13;19(3):161-172. doi: 10.1021/acscombsci.6b00174. Epub 2017 Feb 22.

引用本文的文献

8
Discovery of CHD1 Antagonists for PTEN-Deficient Prostate Cancer.发现 CHD1 拮抗剂用于治疗 PTEN 缺陷型前列腺癌。
J Med Chem. 2024 Nov 28;67(22):20056-20075. doi: 10.1021/acs.jmedchem.4c01172. Epub 2024 Nov 7.
10
How CBX proteins regulate normal and leukemic blood cells.CBX 蛋白如何调节正常和白血病血细胞。
FEBS Lett. 2024 Nov;598(22):2788-2806. doi: 10.1002/1873-3468.14839. Epub 2024 Mar 1.

本文引用的文献

6
Cell Penetration Profiling Using the Chloroalkane Penetration Assay.利用氯烷渗透测定法进行细胞渗透分析。
J Am Chem Soc. 2018 Sep 12;140(36):11360-11369. doi: 10.1021/jacs.8b06144. Epub 2018 Aug 31.
7
Revisiting the "Art of the Chemical Probe".再探“化学探针的艺术”。
ACS Chem Biol. 2018 May 18;13(5):1109-1110. doi: 10.1021/acschembio.8b00390.
9
Drug Discovery and Chemical Biology of Cancer Epigenetics.癌症表观遗传学的药物发现和化学生物学。
Cell Chem Biol. 2017 Sep 21;24(9):1120-1147. doi: 10.1016/j.chembiol.2017.08.020.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验